Firoz Ahmed1,2. 1. Department of Biochemistry, College of Science, University of Jeddah, Jeddah, Saudi Arabia. 2. University of Jeddah Center for Scientific and Medical Research, University of Jeddah, Jeddah, Saudi Arabia.
Abstract
BACKGROUND: SARS-CoV-2 causes ongoing pandemic coronavirus disease of 2019 (COVID-19), infects the cells of the lower respiratory tract that leads to a cytokine storm in a significant number of patients resulting in severe pneumonia, shortness of breathing, respiratory and organ failure. Extensive studies suggested the role of Vitamin D in suppressing cytokine storm in COVID-19 and reducing viral infection; however, the precise molecular mechanism is not clearly known. In this work, bioinformatics and systems biology approaches were used to understand SARS-CoV-2 induced cytokine pathways and the potential mechanism of Vitamin D in suppressing cytokine storm and enhancing antiviral response. RESULTS: This study used transcriptome data and identified 108 differentially expressed host genes (DEHGs) in SARS-CoV-2 infected normal human bronchial epithelial (NHBE) cells compared to control. Then, the DEHGs was integrated with the human protein-protein interaction data to generate a SARS-CoV-2 induced host gene regulatory network (SiHgrn). Analysis of SiHgrn identified a sub-network "Cluster 1" with the highest MCODE score, 31 up-regulated genes, and predominantly associated immune and inflammatory response. Interestingly, the iRegulone tool identified that "Cluster 1" is under the regulation of transcription factors STAT1, STAT2, STAT3, POU2F2, and NFkB1, collectively referred to as "host response signature network". Functional enrichment analysis with NDEx revealed that the "host response signature network" is predominantly associated with critical pathways, including "cytokines and inflammatory response", "non-genomic action of Vitamin D", "the human immune response to tuberculosis", and "lung fibrosis". Finally, in-depth analysis and literature mining revealed that Vitamin D binds with its receptor and could work through two different pathways: (i) it inhibits the expression of pro-inflammatory cytokines through blocking the TNF induced NFkB1 signaling pathway; and (ii) it initiates the expression of interferon-stimulating genes (ISGs) for antiviral defense program through activating the IFN-α induced Jak-STAT signaling pathway. CONCLUSION: This comprehensive study identified the pathways associated with cytokine storm in SARS-CoV-2 infection. The proposed underlying mechanism of Vitamin D could be promising in suppressing the cytokine storm and inducing a robust antiviral response in severe COVID-19 patients. The finding in this study urgently needs further experimental validations for the suitability of Vitamin D in combination with IFN-α to control severe COVID-19.
BACKGROUND: SARS-CoV-2 causes ongoing pandemic coronavirus disease of 2019 (COVID-19), infects the cells of the lower respiratory tract that leads to a cytokine storm in a significant number of patients resulting in severe pneumonia, shortness of breathing, respiratory and organ failure. Extensive studies suggested the role of Vitamin D in suppressing cytokine storm in COVID-19 and reducing viral infection; however, the precise molecular mechanism is not clearly known. In this work, bioinformatics and systems biology approaches were used to understand SARS-CoV-2 induced cytokine pathways and the potential mechanism of Vitamin D in suppressing cytokine storm and enhancing antiviral response. RESULTS: This study used transcriptome data and identified 108 differentially expressed host genes (DEHGs) in SARS-CoV-2 infected normal human bronchial epithelial (NHBE) cells compared to control. Then, the DEHGs was integrated with the human protein-protein interaction data to generate a SARS-CoV-2 induced host gene regulatory network (SiHgrn). Analysis of SiHgrn identified a sub-network "Cluster 1" with the highest MCODE score, 31 up-regulated genes, and predominantly associated immune and inflammatory response. Interestingly, the iRegulone tool identified that "Cluster 1" is under the regulation of transcription factors STAT1, STAT2, STAT3, POU2F2, and NFkB1, collectively referred to as "host response signature network". Functional enrichment analysis with NDEx revealed that the "host response signature network" is predominantly associated with critical pathways, including "cytokines and inflammatory response", "non-genomic action of Vitamin D", "the human immune response to tuberculosis", and "lung fibrosis". Finally, in-depth analysis and literature mining revealed that Vitamin D binds with its receptor and could work through two different pathways: (i) it inhibits the expression of pro-inflammatory cytokines through blocking the TNF induced NFkB1 signaling pathway; and (ii) it initiates the expression of interferon-stimulating genes (ISGs) for antiviral defense program through activating the IFN-α induced Jak-STAT signaling pathway. CONCLUSION: This comprehensive study identified the pathways associated with cytokine storm in SARS-CoV-2 infection. The proposed underlying mechanism of Vitamin D could be promising in suppressing the cytokine storm and inducing a robust antiviral response in severe COVID-19 patients. The finding in this study urgently needs further experimental validations for the suitability of Vitamin D in combination with IFN-α to control severe COVID-19.
Authors: Aimee K Zaas; Minhua Chen; Jay Varkey; Timothy Veldman; Alfred O Hero; Joseph Lucas; Yongsheng Huang; Ronald Turner; Anthony Gilbert; Robert Lambkin-Williams; N Christine Øien; Bradly Nicholson; Stephen Kingsmore; Lawrence Carin; Christopher W Woods; Geoffrey S Ginsburg Journal: Cell Host Microbe Date: 2009-08-06 Impact factor: 21.023
Authors: M J Adams; E J Lefkowitz; A M Q King; D H Bamford; M Breitbart; A J Davison; S A Ghabrial; A E Gorbalenya; N J Knowles; P Krell; R Lavigne; D Prangishvili; H Sanfaçon; S G Siddell; P Simmonds; E B Carstens Journal: Arch Virol Date: 2015-07 Impact factor: 2.574
Authors: Laura A Hancock; Corinne E Hennessy; George M Solomon; Evgenia Dobrinskikh; Alani Estrella; Naoko Hara; David B Hill; William J Kissner; Matthew R Markovetz; Diane E Grove Villalon; Matthew E Voss; Guillermo J Tearney; Kate S Carroll; Yunlong Shi; Marvin I Schwarz; William R Thelin; Steven M Rowe; Ivana V Yang; Christopher M Evans; David A Schwartz Journal: Nat Commun Date: 2018-12-18 Impact factor: 14.919
Authors: Anne O'Garra; Paul S Redford; Finlay W McNab; Chloe I Bloom; Robert J Wilkinson; Matthew P R Berry Journal: Annu Rev Immunol Date: 2013 Impact factor: 28.527
Authors: Hani Choudhry; Muhammed A Bakhrebah; Wesam H Abdulaal; Mazin A Zamzami; Othman A Baothman; Mohammed A Hassan; Mustafa Zeyadi; Nawal Helmi; Faisal Alzahrani; Ashraf Ali; Mohammad Khalid Zakaria; Mohammad Azhar Kamal; Mohiuddin Khan Warsi; Firoz Ahmed; Mahmood Rasool; Mohammad Sarwar Jamal Journal: Future Virol Date: 2019-04-18 Impact factor: 1.831
Authors: Jose Manuel Quesada-Gomez; José Lopez-Miranda; Marta Entrenas-Castillo; Antonio Casado-Díaz; Xavier Nogues Y Solans; José Luis Mansur; Roger Bouillon Journal: Nutrients Date: 2022-06-29 Impact factor: 6.706
Authors: F Coperchini; A Greco; M Denegri; F A Ripepi; B Grillini; J Bertini; B Calì; L Villani; F Magri; L Croce; C Gaetano; C Cappelli; P Trimboli; L Chiovato; M Rotondi Journal: J Endocrinol Invest Date: 2022-07-12 Impact factor: 5.467
Authors: Mohd Rehan; Firoz Ahmed; Saad M Howladar; Mohammed Y Refai; Hanadi M Baeissa; Torki A Zughaibi; Khalid Mohammed Kedwa; Mohammad Sarwar Jamal Journal: Front Immunol Date: 2021-06-24 Impact factor: 7.561